Ozempic Guide
Ozempic is Novo Nordisk's brand of semaglutide for type 2 diabetes. It comes as a once-weekly injection (0.25 mg to start, then 0.5, 1 or 2 mg) and, since May 4, 2026, as Ozempic tablets taken once a day (1.5, 4 or 9 mg), which replace Rybelsus in the US. It is widely prescribed off-label for weight loss. The injection's label also names two protective uses in type 2 diabetes: fewer major heart events in people who already have heart disease, and slower loss of kidney function, with fewer kidney failures and cardiovascular deaths, in people with chronic kidney disease. The tablets carry the heart-event use, for adults at high risk, but not the kidney one.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
At a Glance
| Generic Name | Semaglutide |
| Brand Names | Ozempic |
| FDA Status | Injection: FDA-approved for glycemic control in type 2 diabetes (December 2017), to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease (2020), and to reduce kidney function decline, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (January 2025). Ozempic tablets, taken once daily and on sale since May 4, 2026, share Rybelsus's label: glycemic control in adults with type 2 diabetes and fewer major cardiovascular events in those at high risk. Weight loss is off-label use.[1] |
| Approval Date | December 5, 2017[1] |
Ozempic also comes as a pill. Ozempic tablets, taken once a day at 1.5, 4 or 9 mg, went on sale on May 4, 2026 and replace Rybelsus in the US. Our guide to Ozempic tablets covers the doses, the empty-stomach rule and the price. If you take Rybelsus now, the article on why Rybelsus is being discontinued explains how its doses map onto the new tablets.
How does Ozempic work?
Ozempic activates GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, and reduce blood sugar levels. The same mechanism that controls blood glucose also suppresses appetite and slows gastric emptying, producing significant weight loss as a secondary effect. At 1–2mg doses, Ozempic delivers strong appetite suppression comparable to Wegovy's lower dose range.[2][3]
Dosing Schedule — Injection
Ozempic uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].
Dosing Schedule — Ozempic tablets
What side effects does Ozempic cause?
Common: nausea, vomiting, diarrhea, stomach pain, constipation. Injection site reactions are common in early weeks. Serious (rare): pancreatitis, diabetic retinopathy worsening, kidney injury, hypoglycemia when combined with sulfonylureas or insulin. Thyroid C-cell tumor risk noted in animal studies.[1][2]
Nothing above is the full list. Your prescriber can give you the complete safety picture, and every adverse reaction on record sits in the current FDA prescribing information[1].
Clinical Trial Results
In the SUSTAIN-6 cardiovascular trial, Ozempic reduced the risk of major cardiovascular events by 26% vs. placebo (Marso et al. NEJM 2016, PMID 27633186). For weight loss specifically, the STEP-8 head-to-head trial (Rubino et al. JAMA 2022, PMID 35015037) used semaglutide 2.4 mg — the Wegovy dose, not the Ozempic 1 mg dose — and showed 15.8% weight loss vs 6.4% for liraglutide 3 mg. The approvals do not overlap: type 2 diabetes is the whole of Ozempic's label, and chronic weight management belongs to Wegovy, the other semaglutide.[2]
Where can you get Ozempic?
Sellers in our register that will dispense semaglutide, or a compounded version of it, after an online consultation — shipped to your door.
altRX
Best for: compounded semaglutide from $89/month at the same price at every dose
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Wellorithm
Best for: compounded semaglutide at a flat $247 every 28 days, any dose
Editorial score · methodology
How much does Ozempic cost?
43 sellers in the register publish a price; the lowest starts at $149 a month, checked November 2026. What each one charges to start, cheapest at the top. Compounded semaglutide from state-licensed 503A pharmacies is legal under federal compounding law when made for an individual patient[4], and the rules loosen further, to include bulk compounding by 503B outsourcing facilities, only while a molecule sits on the FDA Drug Shortage List[5]. An FSA or HSA will generally cover either kind of prescription, compounded or branded, under IRS Publication 502[6]. What you actually pay moves with your dose and with whatever promotion happens to be running.
| Provider | Starting Price | Link | |
|---|---|---|---|
| NovoCare Pharmacy | brand | $149/mo | Visit |
| Mochi Health | brand | $199/mo + membership | Visit |
| GOAL.MD | brand | $244/mo | Visit |
| Knownwell | brand | $349/mo + visit fee | Visit |
| Sesame Care | brand | $349/mo + care fee | Visit |
| Maximus | brand | $349.99/mo | Visit |
| Synergy Rx | brand | $499/mo | Visit |
| Care Bare Rx | brand | $705/mo | Visit |
| Vital Edge | brand | $705/mo | Visit |
| altRX | brand | $1,149/mo | Visit |
Show all 43 Ozempic sellersShowing all 43 sellers
| Wellya | brand | $1,149/mo | Visit |
| NoBsRx | brand | $1,199/mo | Visit |
| Wellorithm | brand | $1,199/mo, prepaid | Visit |
| Astra | brand | $1,200/mo | Visit |
| Oak | brand | $1,250/mo | Visit |
| Aquivia Health | brand | $1,299/mo | Visit |
| Gala | brand | $1,299/mo | Visit |
| Josie | brand | $1,299/mo | Visit |
| Luvo Health | brand | $1,299/mo | Visit |
| Pallas Health | brand | $1,299/mo | Visit |
| Peptivo | brand | $1,299/mo | Visit |
| Remmy | brand | $1,299/mo | Visit |
| RxSpan MD | brand | $1,299/mo | Visit |
| Trimrose | brand | $1,299/mo | Visit |
| TrimRx | brand | $1,299/mo | Visit |
| Tryozi | brand | $1,299/mo | Visit |
| VivioMD | brand | $1,299/mo | Visit |
| XMD Wellness | brand | $1,299/mo | Visit |
| Effecty | brand | $1,300/mo | Visit |
| AlyveRx | brand | $1,395/mo | Visit |
| Elevated Health | brand | $1,399/mo | Visit |
| Eve | brand | $1,399/mo | Visit |
| Layla | brand | $1,399/mo | Visit |
| WellMedRx | brand | $1,399/mo | Visit |
| SkinnyRx | brand | $1,400/mo | Visit |
| myRocky | brand | $1,409/mo + program fee | Visit |
| Fridays | brand | $1,498/mo | Visit |
| Nucific | brand | $1,498/mo | Visit |
| NuuVim | brand | $1,498/mo | Visit |
| Corsica Health | brand | $1,499/mo | Visit |
| Good Girl Rx | brand | $1,580/mo | Visit |
| DudeMeds | brand | $1,585/mo | Visit |
| Concierge MD LA | brand | $1,999/mo | Visit |
Ozempic Head-to-Head Comparisons
Short verdict pages setting Ozempic against the other GLP-1 options, working from the trial results, the dose ladders on each label, and what the manufacturers charge today.
See all drug-vs-drug verdicts.
Pivotal Ozempic Trial Walkthroughs
The trials that produced the Ozempic label, taken endpoint by endpoint, with the figures read off the source.
Ozempic Patient Questions, Answered
Questions people actually asked about Ozempic in named subreddits, each answered from the published trial data.
Ozempic Reference Cards
One-screen references for the dose schedule, what to do about a missed dose, and the side effects that warrant a call. Every figure checked against the DailyMed label.
Ranked PubMed Studies on Ozempic
The peer-reviewed studies on Ozempic and its neighbours that carry the most weight, gathered into lists. Every PMID was checked against PubMed esummary rather than recalled.
Related Research on Ozempic
Longer pieces written here, built on the trial papers themselves, checked against the FDA label, and argued rather than summarized.
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 2.SUSTAIN-6 Trial — Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (Marso SP et al.)— New England Journal of Medicine.PMID: 27633186.
- 3.ADA — Standards of Care in Diabetes (2025)— American Diabetes Association.
- 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Wegovy · Drugs and brands
- Rybelsus · Drugs and brands
- GLP-1 receptor · Mechanism
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
- Ozempic face · Side effects